Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview


« Back to Dashboard
Morphine Sulfate is a drug marketed by Novel Labs Inc, Upsher Smith, Dava Pharms Inc, Roxane, Hospira, Vintage Pharms Llc, Impax Labs Inc, Nostrum Labs Inc, Par Pharm Inc, Mallinckrodt, Hospira Inc, Lannett Holdings Inc, Teva Pharms Usa, Tris Pharma Inc, Rhodes Pharms, Nesher Pharms, Fresenius Kabi Usa, Mylan Pharms Inc, Sun Pharm Inds Ltd, Actavis Elizabeth, Vistapharm, Mallinckrodt Inc, Watson Labs, Corepharma, Eurohlth Intl Sarl, Paddock Llc, and Meridian Medcl Techn. and is included in forty-nine NDAs. It is available from forty-two suppliers. There are three patents protecting this drug.

This drug has fourteen patent family members in seven countries.

The generic ingredient in MORPHINE SULFATE is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: MORPHINE SULFATE

Suppliers / Packagers: see list42
Drug Prices: :see details

Pharmacology for Tradename: MORPHINE SULFATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Clinical Trials for: MORPHINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-004Oct 30, 2013RXYes9,192,608Mar 12, 2034
morphine sulfate
SOLUTION;ORAL201947-001Jan 5, 2012RXNo
Hospira Inc
morphine sulfate
INJECTABLE;INJECTION202515-005Nov 14, 2011RXYes
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MORPHINE SULFATE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014140097► subscribe
Australia2014230836► subscribe
European Patent Office2968729► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.